BIT:SVS • IT0005469264
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SVAS BIOSANA SPA (SVS.MI).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 97.227M 19.91% | 118.284M 21.66% | 120.315M 1.72% | 145.95M 21.31% | 153.17M 4.95% | 158.82M 3.69% | |
| EBITDA YoY % growth | 11.716M 8.20% | 14.092M 20.28% | 15.536M 10.25% | 18.736M 20.60% | 19.897M 6.20% | 20.756M 4.32% | |
| EBIT YoY % growth | 6.926M 10.02% | 9.073M 30.99% | 10.288M 13.40% | 12.423M 20.75% | 13.08M 5.29% | 14.191M 8.49% | |
| Operating Margin | 7.12% | 7.67% | 8.55% | 8.51% | 8.54% | 8.94% | |
| EPS YoY % growth | N/A -9.86% | N/A 35.94% | N/A 20.69% | 1.41 33.33% | 1.47 4.29% | 1.61 8.90% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
6 analysts have analysed SVS.MI and the average price target is 17.44 EUR. This implies a price increase of 97.31% is expected in the next year compared to the current price of 8.84.
The consensus rating for SVAS BIOSANA SPA (SVS.MI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.